Variant report

Variant	nsv602961
Chromosome Location	chr6:38875752-38901236
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:97)
CpG islands
(count:122)
Chromatin interactive
region (count:19)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:97 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:38877137-38877544	HepG2	liver:	n/a	n/a
2	BHLHE40	chr6:38877338-38877466	HepG2	liver:	n/a	n/a
3	CEBPB	chr6:38877070-38877471	HepG2	liver:	n/a	n/a
4	CEBPB	chr6:38877137-38877348	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr6:38877089-38877420	MCF-7	breast:	n/a	n/a
6	CEBPB	chr6:38886888-38887081	K562	blood:	n/a	chr6:38886956-38886969
7	CEBPB	chr6:38878012-38878350	K562	blood:	n/a	n/a
8	CEBPB	chr6:38877083-38877379	IMR90	lung:	n/a	n/a
9	CEBPB	chr6:38877082-38877357	ECC-1	luminal epithelium:	n/a	n/a
10	CEBPB	chr6:38877091-38877316	A549	lung:	n/a	n/a
11	CEBPB	chr6:38877037-38877581	HepG2	liver:	n/a	n/a
12	CEBPB	chr6:38877061-38877401	K562	blood:	n/a	n/a
13	CEBPB	chr6:38876989-38877363	HepG2	liver:	n/a	n/a
14	CEBPB	chr6:38878013-38878349	HepG2	liver:	n/a	n/a
15	CEBPB	chr6:38878073-38878262	H1-hESC	embryonic stem cell:	n/a	n/a
16	CEBPB	chr6:38878047-38878243	HepG2	liver:	n/a	n/a
17	CEBPB	chr6:38878043-38878308	Hela-S3	cervix:	n/a	n/a
18	CEBPB	chr6:38877061-38877388	Hela-S3	cervix:	n/a	n/a
19	CEBPB	chr6:38877059-38877302	HepG2	liver:	n/a	n/a
20	CREB1	chr6:38876982-38877479	HepG2	liver:	n/a	n/a
21	CREB1	chr6:38876971-38877573	HepG2	liver:	n/a	n/a
22	CTCF	chr6:38897534-38897584	GM12878	blood:	n/a	n/a
23	CTCF	chr6:38900740-38900890	HEK293	kidney:	n/a	n/a
24	CTCF	chr6:38901140-38901290	A549	lung:	n/a	n/a
25	CTCF	chr6:38900860-38901010	SAEC	small airway:	n/a	n/a
26	CTCF	chr6:38901103-38901712	MCF-7	breast:	n/a	n/a
27	CTCF	chr6:38901173-38901575	HepG2	liver:	n/a	n/a
28	CTCF	chr6:38901210-38901593	K562	blood:	n/a	n/a
29	CTCF	chr6:38897600-38897750	HMEC	breast:	n/a	n/a
30	CTCF	chr6:38901205-38901593	GM12878	blood:	n/a	n/a
31	CTCF	chr6:38901086-38901608	MCF-7	breast:	n/a	n/a
32	CTCF	chr6:38901131-38901751	A549	lung:	n/a	n/a
33	CTCF	chr6:38901220-38901370	HFF-Myc	foreskin:	n/a	n/a
34	CTCF	chr6:38900973-38901714	SK-N-SH	brain:	n/a	n/a
35	CTCF	chr6:38897398-38897655	K562	blood:	n/a	n/a
36	CTCF	chr6:38897495-38897641	HUVEC	blood vessel:	n/a	n/a
37	CTCF	chr6:38880100-38880180	Fibrobl	skin:	n/a	n/a
38	CTCF	chr6:38901200-38901350	A549	lung:	n/a	n/a
39	CTCF	chr6:38901200-38901350	AG04450	lung:	n/a	n/a
40	CTCF	chr6:38901078-38901705	HCT-116	colon:	n/a	n/a
41	CTCF	chr6:38897482-38897658	LNCaP	prostate:	n/a	n/a
42	CTCF	chr6:38897505-38897625	K562	blood:	n/a	n/a
43	CTCF	chr6:38897492-38897640	LNCaP	prostate:	n/a	n/a
44	EP300	chr6:38877072-38877472	HepG2	liver:	n/a	chr6:38877273-38877283
45	EP300	chr6:38877037-38877435	HepG2	liver:	n/a	chr6:38877273-38877283
46	FOXA1	chr6:38877113-38877572	HepG2	liver:	n/a	n/a
47	FOXA1	chr6:38877122-38877501	HepG2	liver:	n/a	n/a
48	FOXA1	chr6:38876975-38877544	HepG2	liver:	n/a	n/a
49	FOXA1	chr6:38877040-38877576	HepG2	liver:	n/a	n/a
50	FOXA1	chr6:38879703-38880004	T-47D	breast:	n/a	chr6:38879857-38879869 chr6:38879778-38879790

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:38896772-38896822	HCM	heart:	n/a
2	chr6:38896772-38896822	SKMC	muscle:	n/a
3	chr6:38894231-38894281	PANC-1	pancreas:	n/a
4	chr6:38896772-38896822	HNPCEpiC	eye:	n/a
5	chr6:38896772-38896822	AG10803	skin:	n/a
6	chr6:38896772-38896822	T-47D	breast:	n/a
7	chr6:38896772-38896822	GM19239	blood:	n/a
8	chr6:38896772-38896822	AG09309	skin:	n/a
9	chr6:38896772-38896822	HUVEC	blood vessel:	n/a
10	chr6:38894231-38894281	GM12878	blood:	n/a
11	chr6:38894231-38894281	A549	lung:	n/a
12	chr6:38894231-38894281	HEEpiC	esophagus:	n/a
13	chr6:38894231-38894281	GM06990	blood:	n/a
14	chr6:38894231-38894281	SAEC	small airway:	n/a
15	chr6:38896772-38896822	SK-N-MC	brain:	n/a
16	chr6:38896772-38896822	HEEpiC	esophagus:	n/a
17	chr6:38896772-38896822	HepG2	liver:	n/a
18	chr6:38894231-38894281	HRE	kidney:	n/a
19	chr6:38894231-38894281	AG09319	gingival:	n/a
20	chr6:38896772-38896822	HRE	kidney:	n/a
21	chr6:38896772-38896822	A549	lung:	n/a
22	chr6:38894231-38894281	HPAEpiC	pulmonary alveolar:	n/a
23	chr6:38894231-38894281	HUVEC	blood vessel:	n/a
24	chr6:38894231-38894281	CMK	blood:	n/a
25	chr6:38894231-38894281	LNCaP	prostate:	n/a
26	chr6:38896772-38896822	SK-N-SH_RA	brain:	n/a
27	chr6:38896772-38896822	PFSK-1	brain:	n/a
28	chr6:38894231-38894281	HRCEpiC	kidney:	n/a
29	chr6:38894231-38894281	HIPEpiC	eye:	n/a
30	chr6:38894231-38894281	BJ	skin:	n/a
31	chr6:38896772-38896822	HRPEpiC	eye:	n/a
32	chr6:38894231-38894281	HepG2	liver:	n/a
33	chr6:38894231-38894281	SK-N-SH_RA	brain:	n/a
34	chr6:38894231-38894281	BE2_C	brain:	n/a
35	chr6:38894231-38894281	MCF10A-Er-Src	breast:	n/a
36	chr6:38894231-38894281	NT2-D1	testis:	n/a
37	chr6:38896772-38896822	HAEpiC	amniotic membrane:	n/a
38	chr6:38894231-38894281	ovcar-3	ovarian:	n/a
39	chr6:38894231-38894281	AoSMC	blood vessel:	n/a
40	chr6:38896772-38896822	HRCEpiC	kidney:	n/a
41	chr6:38896772-38896822	PANC-1	pancreas:	n/a
42	chr6:38894231-38894281	ECC-1	luminal epithelium:	n/a
43	chr6:38896772-38896822	GM06990	blood:	n/a
44	chr6:38896772-38896822	MCF10A-Er-Src	breast:	n/a
45	chr6:38896772-38896822	BE2_C	brain:	n/a
46	chr6:38894231-38894281	HEK293	kidney:	embryo
47	chr6:38896772-38896822	PrEC	prostate:	n/a
48	chr6:38894231-38894281	HAEpiC	amniotic membrane:	n/a
49	chr6:38896772-38896822	HCPEpiC	choroid plexus:	n/a
50	chr6:38894231-38894281	RPTEC	kidney:	n/a

(count:19 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:38896535..38899367-chr6:38900906..38902876,2	MCF-7	breast:
2	chr6:38884806..38886853-chr6:38889455..38891873,2	K562	blood:
3	chr6:38877103..38879677-chr6:38880412..38883023,2	K562	blood:
4	chr6:38773740..38774704-chr6:38901124..38901864,4	MCF-7	breast:
5	chr6:38839463..38840459-chr6:38901033..38901837,4	MCF-7	breast:
6	chr6:38885137..38887248-chr6:38897981..38900186,2	K562	blood:
7	chr6:38882569..38884990-chr6:38896928..38898795,2	K562	blood:
8	chr6:38763255..38763863-chr6:38901115..38901700,2	MCF-7	breast:
9	chr6:38839518..38840375-chr6:38900813..38901849,3	MCF-7	breast:
10	chr6:38884806..38886853-chr6:38889455..38891873,2	K562	blood:
11	chr6:38877864..38879774-chr6:38880204..38883069,2	K562	blood:
12	chr6:38901008..38902530-chr6:38905671..38907488,2	K562	blood:
13	chr6:38877103..38879677-chr6:38880412..38883023,2	K562	blood:
14	chr6:38879702..38881933-chr6:38883496..38885516,2	MCF-7	breast:
15	chr6:38882569..38884990-chr6:38896928..38898795,2	K562	blood:
16	chr6:38868758..38870496-chr6:38873013..38875836,2	K562	blood:
17	chr6:38839504..38840084-chr6:38897171..38897919,2	MCF-7	breast:
18	chr6:38877864..38879774-chr6:38880204..38883069,2	K562	blood:
19	chr6:38879702..38881933-chr6:38883496..38885516,2	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SAYSD1-1	chr6:38900773-38900879	NONHSAT112341
2	lnc-SAYSD1-1	chr6:38899109-38899149	NONHSAT112341

No data

Variant related genes	Relation type
ENSG00000220076	TF binding region
ENSG00000231150	TF binding region
ENSG00000220076	CpG island
ENSG00000231150	CpG island
ENSG00000231150	chromatin interactions

Extended variants
information (count: 764 )
Associated
traits (count: 94 )

Variant overlapped rSNPs/rCNVs (count:764 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4452640	chr6:38875752-38875753	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs142453787	chr6:38875758-38875759	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs199746766	chr6:38875799-38875800	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs151313083	chr6:38875810-38875811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs565304500	chr6:38875818-38875819	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs200974923	chr6:38875821-38875822	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs542352054	chr6:38875902-38875903	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs147204268	chr6:38875911-38875912	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs372391866	chr6:38875913-38875914	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs201271697	chr6:38875921-38875922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs375580813	chr6:38875924-38875925	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs536243845	chr6:38875925-38875926	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs550156996	chr6:38876003-38876004	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs570067956	chr6:38876069-38876070	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs539107329	chr6:38876176-38876177	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs148687474	chr6:38876182-38876183	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs577744675	chr6:38876198-38876199	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs142199308	chr6:38876216-38876217	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs575615178	chr6:38876229-38876230	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs193168820	chr6:38876272-38876273	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs79655111	chr6:38876273-38876274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs201299548	chr6:38876342-38876343	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs11758513	chr6:38876380-38876381	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs562593860	chr6:38876431-38876432	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs564804781	chr6:38876556-38876557	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs542518381	chr6:38876566-38876567	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs140066931	chr6:38876586-38876587	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs375590731	chr6:38876633-38876634	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs575650245	chr6:38876667-38876668	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs182851578	chr6:38876670-38876671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs565019896	chr6:38876691-38876692	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs527878685	chr6:38876814-38876815	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs548011232	chr6:38876819-38876820	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs561333989	chr6:38876835-38876836	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs530368572	chr6:38876839-38876840	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs112803830	chr6:38876878-38876879	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs550515322	chr6:38876888-38876889	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs370245506	chr6:38876902-38876903	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs9380808	chr6:38876929-38876930	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs4714197	chr6:38876942-38876943	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs143998150	chr6:38876962-38876963	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs566209307	chr6:38877034-38877035	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs111555117	chr6:38877081-38877082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs113934697	chr6:38877121-38877122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs567372582	chr6:38877163-38877164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs536109922	chr6:38877225-38877226	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs200874008	chr6:38877252-38877253	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs575613410	chr6:38877315-38877316	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs140935840	chr6:38877354-38877355	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs368597183	chr6:38877361-38877362	Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:94)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Ovarian cancer	21720365	CNVD
Melanoma	21693616	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Breast cancer	16397240	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	17603634	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Cancer	20164919	CNVD
Glioblastoma multiforme	21510904	CNVD
Amyotrophic lateral sclerosis	20685689	CNVD

Chromatin state (count:76 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:38874600-38878200	Enhancers	Stomach Mucosa	stomach
2	chr6:38875000-38876000	Enhancers	Fetal Intestine Small	intestine
3	chr6:38875000-38876800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr6:38875400-38877200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
5	chr6:38875600-38876800	Weak transcription	Fetal Intestine Large	intestine
6	chr6:38876000-38876400	Weak transcription	Fetal Intestine Small	intestine
7	chr6:38876200-38876600	Enhancers	Fetal Muscle Leg	muscle
8	chr6:38876200-38877200	Enhancers	HSMMtube	muscle
9	chr6:38876400-38877600	Enhancers	Muscle Satellite Cultured Cells	--
10	chr6:38876400-38878800	Enhancers	Fetal Intestine Small	intestine
11	chr6:38876800-38877600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
12	chr6:38876800-38878400	Enhancers	Fetal Intestine Large	intestine
13	chr6:38877000-38877600	Enhancers	HSMM	muscle
14	chr6:38877000-38878200	Enhancers	Liver	Liver
15	chr6:38877000-38878400	Enhancers	HepG2	liver
16	chr6:38877200-38877400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr6:38877200-38877400	Enhancers	Gastric	stomach
18	chr6:38877200-38877600	Flanking Active TSS	HSMMtube	muscle
19	chr6:38877400-38877800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
20	chr6:38877600-38878200	Enhancers	HSMMtube	muscle
21	chr6:38877600-38878600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
22	chr6:38877800-38878200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
23	chr6:38877800-38878200	Enhancers	Gastric	stomach
24	chr6:38878200-38882400	Weak transcription	Stomach Mucosa	stomach
25	chr6:38878600-38878800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr6:38885200-38886600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
27	chr6:38886600-38888400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr6:38888400-38888600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
29	chr6:38888600-38889000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
30	chr6:38889000-38889200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
31	chr6:38889000-38890000	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
32	chr6:38889000-38890200	Enhancers	ES-I3 Cell Line	embryonic stem cell
33	chr6:38889000-38892800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
34	chr6:38889000-38895400	Enhancers	HUES6 Cell Line	embryonic stem cell
35	chr6:38889200-38889400	Enhancers	ES-WA7 Cell Line	embryonic stem cell
36	chr6:38889200-38889400	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr6:38889200-38890200	Enhancers	HUES48 Cell Line	embryonic stem cell
38	chr6:38889200-38890200	Enhancers	iPS-15b Cell Line	embryonic stem cell
39	chr6:38889400-38890000	Weak transcription	HUES64 Cell Line	embryonic stem cell
40	chr6:38889400-38890200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
41	chr6:38889400-38890200	Enhancers	H9 Cell Line	embryonic stem cell
42	chr6:38889400-38890200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
43	chr6:38889800-38890200	Enhancers	H1 Cell Line	embryonic stem cell
44	chr6:38890000-38890200	Enhancers	HUES64 Cell Line	embryonic stem cell
45	chr6:38890000-38890200	Enhancers	iPS-20b Cell Line	embryonic stem cell
46	chr6:38890200-38890600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
47	chr6:38890200-38891400	Weak transcription	H9 Cell Line	embryonic stem cell
48	chr6:38890200-38893200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
49	chr6:38890200-38893200	Weak transcription	H1 Cell Line	embryonic stem cell
50	chr6:38890200-38893400	Weak transcription	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links